Literature DB >> 25168937

Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing.

Jerrold H Levy1, Fania Szlam2, Alisa S Wolberg3, Anne Winkler4.   

Abstract

Although the activated partial thromboplastin time, prothrombin time, and international normalized ratio are widely used in routine preoperative testing, these hemostatic tests are not reliable predictors of perioperative bleeding in patients without known bleeding risk factors. In contrast, a preoperative bleeding history and physical examination are usually obtained in an attempt to identify important bleeding risk factors. However, these coagulation tests are used extensively for monitoring anticoagulation with different pharmacologic agents.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Activated clotting time; Activated partial thromboplastin time; Anticoagulation; Monitoring; Prothrombin time; Surgery

Mesh:

Substances:

Year:  2014        PMID: 25168937     DOI: 10.1016/j.cll.2014.06.005

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  11 in total

Review 1.  Point of care whole blood microfluidics for detecting and managing thrombotic and bleeding risks.

Authors:  Scott L Diamond; Jason M Rossi
Journal:  Lab Chip       Date:  2021-09-28       Impact factor: 7.517

2.  Determining an approximate minimum toxic dosage of diphacinone in horses and corresponding serum, blood, and liver diphacinone concentrations: a pilot study.

Authors:  Megan C Romano; Kyle A Francis; Jennifer G Janes; Robert H Poppenga; Michael S Filigenzi; Darko Stefanovski; Cynthia L Gaskill
Journal:  J Vet Diagn Invest       Date:  2022-04-02       Impact factor: 1.569

Review 3.  Microphysiological systems for the modeling of wound healing and evaluation of pro-healing therapies.

Authors:  Halston E Deal; Ashley C Brown; Michael A Daniele
Journal:  J Mater Chem B       Date:  2020-08-19       Impact factor: 6.331

4.  Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk.

Authors:  Elena N Lipets; Fazoil I Ataullakhanov
Journal:  Thromb J       Date:  2015-01-23

Review 5.  Coagulation Pathways in Neurological Diseases: Multiple Sclerosis.

Authors:  Nicole Ziliotto; Francesco Bernardi; Dejan Jakimovski; Robert Zivadinov
Journal:  Front Neurol       Date:  2019-04-24       Impact factor: 4.003

Review 6.  Tannins as Hemostasis Modulators.

Authors:  Natalia Marcińczyk; Anna Gromotowicz-Popławska; Michał Tomczyk; Ewa Chabielska
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

7.  Effect of urban air pollution on CRP and coagulation: a study on inpatients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Lingling Tang; Suofang Shi; Bohan Wang; Li Liu; Ying Yang; Xianhong Sun; Zhenhua Ni; Xiongbiao Wang
Journal:  BMC Pulm Med       Date:  2021-09-18       Impact factor: 3.317

8.  Assessing Coagulation Parameters in Healthy Asian Elephants (Elephas maximus) from European and Thai Populations.

Authors:  Sónia A Jesus; Anke Schmidt; Jörns Fickel; Marcus G Doherr; Khajohnpat Boonprasert; Chatchote Thitaram; Ladawan Sariya; Parntep Ratanakron; Thomas B Hildebrandt
Journal:  Animals (Basel)       Date:  2022-02-02       Impact factor: 2.752

9.  Antithrombotic Potential of Tormentil Extract in Animal Models.

Authors:  Natalia Marcinczyk; Dominika Jarmoc; Agnieszka Leszczynska; Agnieszka Zakrzeska; Karol Kramkowski; Jakub Strawa; Anna Gromotowicz-Poplawska; Ewa Chabielska; Michal Tomczyk
Journal:  Front Pharmacol       Date:  2017-08-15       Impact factor: 5.810

Review 10.  The Composition and Physical Properties of Clots in COVID-19 Pathology.

Authors:  Sierk Dauwerse; Hugo Ten Cate; Henri M H Spronk; Magdolna Nagy
Journal:  Diagnostics (Basel)       Date:  2022-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.